A Proposed Classification of ICD-11 Severity Degrees of Personality Pathology Using the Self and Interpersonal Functioning Scale.

Background: The 11th version of the World Health Organization's International Classification of Diseases (ICD-11) has adopted a dimensional approach to personality disorder (PD) nosology. Notably, it includes an assessment of PD degree of severity, which can be classified according to five categories. To date, there is no gold standard measure for assessing degree of PD severity based on the ICD-11 model, and there are no empirically-based anchor points to delineate the proposed categories. With the operationalization of PD degrees of severity in the ICD-11 PD model now being closely aligned with Criterion A of the DSM-5 Alternative Model for Personality Disorders (AMPD), sharing a focus on self and interpersonal dysfunction, self-report instruments developed for the latter model might prove useful as screening tools to determine degrees of severity in the former.
Methods: The Self and Interpersonal Functioning Scale, a brief validated self-report questionnaire originally designed to assess level of personality pathology according to the AMPD framework, was used to derive anchor points to delineate the five severity degrees from the ICD-11 PD model. Data from five clinical and non-clinical samples (total N = 2,240) allowed identifying anchor points for classification, based on Receiver Operating Characteristic curve analysis, Latent Class Analysis, and data distribution statistics. Categories were validated using multiple indices pertaining to externalizing and internalizing symptoms relevant to PD.
Results: Analyses yielded the following anchor points for PD degrees of severity: No PD = 0-1.04; Personality Difficulty = 1.05-1.29; Mild PD = 1.30-1.89; Moderate PD = 1.90-2.49; and Severe PD = 2.50 and above. A clear gradient of severity across the five categories was observed in all samples. A high number of significant contrasts among PD categories were also observed on external variables, consistent with the ICD-11 PD degree of severity operationalization. Conclusions: The present study provides potentially useful guidelines to determine severity of personality pathology based on the ICD-11 model. The use of a brief self-report questionnaire as a screening tool for assessing PD degrees of severity should be seen as a time-efficient support for clinical decision and treatment planning.

Introduction

The field of personality disorders (PDs) is moving decisively toward a dimensional conceptualization of personality pathology. Shortcomings of the traditional, categorical method for PD classification have been well-documented [e.g., excessive comorbidity among disorders, heterogeneity within each category, inadequate coverage of PD presentations with an overreliance on “Not otherwise specified” diagnosis, lack of validity of diagnostic categories; e.g., (1, 2)]. It is widely believed that the adoption of a dimensional model of PDs will address these issues, and that a dimensional framework is more consistent with available empirical evidence on the nature of these disorders [e.g., (3–5)].

While calls for moving the field toward a dimensional paradigm are not new [e.g., (6–8)], it is only recently that changes have actually been implemented in the most recent versions of both the Diagnostic and Statistical Manual for Mental Disorders (DSM) and the International Classification of Diseases (ICD). An Alternative Model for Personality Disorders (AMPD) was introduced in Section III of the fifth edition of the DSM (9); it was meant to replace the traditional categorical PD model but was ultimately relegated to Section III by the APA Board of Trustees, awaiting further research. The AMPD includes two main components. Criterion A was proposed as an indicator of the level of personality pathology severity; it includes four elements that are believed to be closely intertwined and focus on impairments in one's sense of self (Identity and Self-direction) and in interpersonal relationships [Empathy and Intimacy; (10)]. Criterion B includes 25 maladaptive personality traits hierarchically organized into five broader domains [Negative Affectivity, Detachment, Antagonism, Disinhibition, and Psychoticism; (11)]. The model also retains six specific personality disorders that can be diagnosed based on “algorithms”; in these algorithms, the presence of two or more Criterion A elements and of Criterion B traits specific to each disorder is necessary for PD diagnosis, making the AMDP a hybrid categorical-dimensional model. Research on the AMPD has burgeoned over the past years and has yielded very promising results [see (12) for a summary].

For its part, the eleventh version of the World Health Organization's (WHO) International Classification of Diseases (ICD-11) has resolutely adopted a dimensional approach to PD nosology [see (4) for a detailed timeline of the different steps that led to the final proposal]. The purpose of the new model was “to provide a classification that was easily understood, could be readily used by practitioners of all disciplines, and that allowed all people with personality disturbance to be recognized” [(4), p. 497]. In the retained model, PD is defined as a marked disturbance in personality functioning, leading to considerable personal and social disruption in most cases. The central manifestations of PD are impairments in self-functioning (e.g., identity, self-worth, self-direction) and/or problems in interpersonal functioning (e.g., developing and maintaining close and mutually satisfying relationships, understanding others' perspectives, managing conflict). Both may manifest in maladaptive (e.g., inflexible, dysregulated) patterns of cognition, affective experience and expression, and behavior. PD can be classified according to a gradient of severity, ranging from (a) “No Personality Disorder,” (b) “Personality Difficulty,” (c) “Mild Personality Disorder,” (d) “Moderate Personality Disorder,” to (e) “Severe Personality Disorder” (13, 14). Table 1 summarizes the main differences among the different degrees of severity. The PD diagnosis may also be specified using one or more “Trait domain qualifiers” (Negative Affectivity, Detachment, Dissociality, Disinhibition, and Anankastia); an additional qualifier for Borderline Pattern may also be used. Of note, initial proposals for ICD-11 PDs did not focus on self and interpersonal dysfunction to define degree of severity, and were more closely aligned with the “British zeitgeist” of PD (15) in which personality pathology tends to be associated with potential of harm to self and others; they also did not include the Borderline specifier. It is only after some vocal opposition was expressed (16) that the initial proposal was amended.

Table 1

Main differences among the ICD-11 degrees of severity for personality disorders.

Personality difficulty	Mild personality disorder	Moderate personality disorder	Severe personality disorder
– Presence of personality characteristics that may affect treatment or health services but fall short of a proper PD diagnosis.	– Disturbances only affect some areas of functioning of the self, or affect all areas but are of mild severity.	– Disturbances affect multiple areas of functioning of the self and are of moderate severity.	– Severe disturbances in multiple areas of functioning of the self.
– Difficulties are expressed only intermittently or at a low level of intensity.	– Some problems are noted in relationships or in performance/social roles, but the individual is able to maintain some of them.	– Marked problems (e.g., conflict, avoidance, extreme dependency) are noted in most relationships, and performance in most social/occupational roles is affected to some degree.	– Serious problems affect virtually all relationships, and the individual is unable or unwilling to perform expected social and occupational roles.
– Difficulties are insufficiently severe to cause significant disruption in social, occupational, and interpersonal relationships or may be limited to specific relationships/situations.	– Not typically associated with significant harm to self or others.	– Sometimes associated with harm to self or others.	– Often associated with harm to self or others.
	– May be associated with substantial distress or with limited to circumscribed impairment in important areas of functioning.	– Associated with marked impairment in most important areas (although functioning in circumscribed areas may be preserved).	– Associated with severe impairment in all (or nearly all) important areas of life.

Adapted from Bach and First (.

Previous research has repeatedly shown that the global degree of PD severity, which will be the focus of this study, predicts a number of negative outcomes over and beyond PD categories. Indeed, general PD severity appears to be a strong predictor of current or future adjustment [e.g., (17–20)]. It also accounts for the comorbidity among categorical PD diagnoses (21) and appears to be sensitive to change (22). Moreover, it may provide valuable information for guiding intensity of clinical treatment [e.g., (13, 23)]. To this day, however, empirical work aiming to operationalize the ICD-11 degrees of severity has been scarce, in contrast with the AMPD Criterion A for which multiple self-report and clinician-rated measures have been developed to assess level of PD severity [see (24, 25) for a summary]. One notable exception is the Standardized Assessment of Severity of Personality Disorder [SASPD; (26)], which was specifically developed to assess the ICD-11 severity of PD. It includes nine items pertaining to traits from each of the five ICD-11 trait model domains; respondents are asked about the impact of a particular problem (e.g., acting on impulse, worrying) on their risk of harm to self and others and on their interpersonal functioning. Initial psychometric evaluation of the SASPD revealed good predictive ability for determining mild and moderate personality disorder severity, and high test-retest stability (26). However, the SASPD was developed based on the initial ICD-11 proposal for PD, and thus did not include elements pertaining to self and interpersonal deficits. In a comparative study of ICD-11 and DSM-5 Section III personality disorder models, McCabe and Widiger (27) found that the SASPD's convergence with the DSM-5 Section III model was improved when combined with the 12-item Level of Personality Functioning Scale-Brief Form [LPFS-BF; (28)], which assesses self and interpersonal impairments in line with the AMPD. McCabe and Widiger (27) concluded that the SASPD might benefit from a revision to include self and interpersonal deficits. In the same vein, in a study comparing the SASPD and the LPFS-BF in their relationships with external correlates, Bach and Anderson (15) outlined that the SASPD appeared to be more closely tied to the initial ICD-11 PD model, i.e., emphasizing risk of harm to self and others, while the LPFS-BF may have better sensitivity in detecting core personality disorder features (i.e., self and interpersonal pathology), which corresponds to the retained model. Furthermore, in a study of the psychometric properties of the SASPD in German non-clinical and clinical samples, Rek et al. (29) found mixed results for convergent and discriminant validity, calling into question its future usage as a screening tool of ICD-11-based degrees of PD severity.

These results, which highlight the potential shortcomings of the SASPD to capture essential features of the final ICD-11 PD model, along with positive results obtained using a self-report initially aimed to operationalize the AMPD, suggest that measures of the latter model might be useful in assessing ICD-11 PD degrees of severity. This “cross walk” strategy was also advocated by Bach and First [(13), p. 6], who stressed that “diagnostic information obtained from assessment tools developed for the DSM-5 AMPD model can be used for making an ICD-11 dimensional Personality Disorder diagnosis.” As aforementioned, there have been numerous self-report questionnaires developed to assess the AMPD that could be useful for that purpose (25). One of these instruments is the Self and Interpersonal Functioning Scale [SIFS; (30)], a 24-item measure originally developed based on the AMPD Criterion A conceptualization. It provides a global personality dysfunction score and four subscale scores, corresponding to AMPD elements (Identity, Self-direction, Empathy, and Intimacy). In its original validation study, meaningful patterns of associations with related psychological constructs (e.g., self-esteem, satisfaction with life, empathy, aggression, pathological narcissism, borderline symptomatology, and AMPD Criterion B domains) were reported. Confirmatory Factor Analysis yielded a second-order model, with four elements organized into a higher-order personality dysfunction factor, consistent with AMPD formulation. In an independent study, content validity analysis of the SIFS items also showed promising results, and the severity level assessed by its items makes it well-suited to study populations with greater psychopathology (25).

The purpose of the present study is to determine, based on the SIFS' global score (i.e., a general indicator of personality impairment), cutoff points corresponding to the five categories in the ICD-11 PD model. Although there might be some irony in “imposing” categories in a fundamentally dimensional framework (31), we believe that these categories are likely to provide clinicians and researchers with useful guidelines, e.g., for treatment planning and level of care assessment [e.g., (13, 23)]. Furthermore, we concur with Rek et al. (29) that accessible and time-efficient PD screening tools are crucial in a context in which these pathologies are too often overlooked during assessment. Providing guidelines for a screening of PD severity based on a short and validated self-report measure such as the SIFS might be a valuable contribution in this regard.

Materials and Methods

Participants and Procedure

A total of 2,240 adults, mainly French-speaking Canadians, were recruited in the Province of Quebec, Canada (84.6% women, Mage = 31.43, SD = 8.66, range 18–79). They were recruited in five distinct samples. The first three correspond to clinical samples. Sample 1 (n = 287) includes prospective PD patients with a more severe clinical presentation, recruited during the intake procedure at a specialized psychiatric outpatient clinic in the Quebec City area. Sample 2 (n = 249) includes prospective PD patients with a less severe clinical presentation, who were also recruited during the intake procedure from different outpatient treatment establishments in the Quebec City area. Both settings are public, and have a mandate of treating PD patients; in line with a stepped care approach [e.g., see (32)], those with more severe clinical presentations are referred to the first clinic for more intensive treatment (Sample 1), while those with less severe presentations are referred to other establishments who offer PD treatment programs but with a less intensive level of care (Sample 2). Sample 3 (n = 242) includes patients from two general private practice clinics located in Quebec City; these clinics use a common set of intake measures as part of a collaborative study. The last two samples correspond to non-clinical participants. Sample 4 (n = 1,200) includes female participants from a study of pregnant women's mental health. They were recruited through advertisement on social media (Facebook and Instagram). Finally, Sample 5 (n = 263) includes participants from the community recruited as part of the initial validation study of the SIFS (30). They were recruited through social media, online message boards, and institutional e-mail from two universities in the Province of Quebec. Supplementary Table 1 provides more detail on socio-demographic characteristics of these five samples.

Measures

Identification of Cutoffs for the ICD-11 PD Severity Degrees

The Self and Interpersonal Functioning Scale (30), described above, was used in our main analyses to determine clinical cutoff points corresponding to the proposed ICD-11 anchors for PD severity, based on its global score (Cronbach's alpha [α] for the combined sample =0.91). Items are rated on a five-point scale (range 0–4). Descriptive statistics for all five samples are displayed in Supplementary Table 2.

External Validation of Degrees of Severity

Samples had different sets of self-report questionnaires, which were used in further analyses to validate the different anchor points established using the SIFS. Supplementary Table 2 displays the different questionnaires from each sample, along with their descriptive statistics (i.e., mean scores and internal consistency indices).

Samples 1, 2, 3, and 5

The Personality Inventory for DSM-5 was used in its 100-item version, the PID-5 Faceted Brief Form [PID-5-FBF; (33); French validation by Roskam et al. (34)] for Samples 1, 3, and 5, and in its 25-item version, the PID-5 Brief Form [PID-5-BF]; (35); French validation by Combaluzier et al. (36)] for Sample 2. It covers five domains of pathological personality functioning: Negative Affectivity, Detachment, Antagonism, Disinhibition, and Psychoticism. Items are rated on a four-point scale (range 0–3).

Samples 1 and 2

The 23-item version of the Borderline Symptom List [BSL-23; (37); French validation by Nicastro et al. (38)] assesses borderline PD symptomatology according to DSM Section II BPD diagnostic criteria, in addition to other affective experiences typical of borderline pathology (e.g., proneness to shame, self-criticism, mistrustfulness). Items are scored on a five-point scale (range 0–4).

The 28-item Brief Version of the Pathological Narcissism Inventory [B-PNI; (39); French validation by Diguer et al. (40)] was used to measure two dimensions of pathological narcissism: Grandiosity (e.g., inflated self-image, exploitative behaviors, fantasies of power and perfection) and Vulnerability (e.g., depleted self-image, shame/anger, interpersonal hypersensitivity). Items are scored on a six-point scale (range 0–5).

Sample 1 Only

The 12-item short-form Buss-Perry Aggression Questionnaire [BPAQ-SF; (41, 42); French validation by Genoud and Zimmerman (43)] covers four manifestations of aggression: Verbal, Physical, Anger, and Hostility. It also yields a global Trait Aggression score. Items are scored on a six-point scale (range 1–6).

The 28-item Interpersonal Reactivity Index [IRI; (44); French validation by Gilet et al. (45)] measures empathy and its components. Two of its subscales were used in the present study: Perspective Taking (the ability to adopt others' point of view), which assesses the cognitive component of empathy, and Empathic Concern (the motivation to care about others), which focuses on the affective component. Items are scored on a seven-point scale (range 1–7).

The 30-item Barratt Impulsiveness Scale [BIS-11; (46); French validation by Baylé et al. (47)] is designed to assess three components of impulsiveness: Attentional, Motor, and Non-planning. Items are scored on a four-point scale (range 1–4).

Sample 3 Only

The 14-item version of the Psychiatric Symptom Index [PSI; (48); French validation by Préville et al. (49)] covers core psychological symptoms (e.g., depression, anxiety, anger). Items are scored on a four-point scale (range 0–3).

The shortened 12-item Experiences in Close Relationship Questionnaire [ECR-12; (50)] assesses both dimensions of romantic attachment: Anxiety about relationship issues, and Avoidance (discomfort with closeness and interdependence). Items are scored on a seven-point scale (range 1–7).

Sample 4 Only

The 10-item Kessler Psychological Distress Scale [K-10; (51) French validation by Gravel et al. (52)] assesses anxious and depressive symptomatology. Items are rated on a five-point scale (range 1–5).

The 10-item Edinburgh Perinatal/Postnatal Depression Scale [EPDS; (53) French validation by Adouard et al. (54)] indicates the presence of depressive symptoms during pregnancy and in the year following childbirth. Items are scored on a four-point scale (range 1–4).

The 20-item Positive and Negative Affect Schedule [PANAS; (55); French validation by Gaudreau et al. (56)] covers the experience of feelings such as energy, enthusiasm, and inspiration (Positive Affect), as well as experiences such as fear, hostility, and shame (Negative Affect). Items are scored on a five-point scale (range 1–5).

Two subscales of the Dissociative Experiences Scale [DES; (57); French validation by Larøi et al. (58)], Absorption/Imaginative involvement (nine items) and Depersonalization/Derealization (six items), were used. Items are rated on an 11-point scale (range 0–10).

The 20-item Posttraumatic Stress Disorder (PTSD) Checklist for DSM-5 [PCL-5; (59); French validation by Ashbaugh et al. (60)] covers trauma-related symptoms aligned with the PTSD diagnostic criteria of the DSM-5. Items are rated on a five-point scale (range 0–4).

Sample 5 Only

The 19-item brief version of the Inventory of Personality Organization (IPO) validated by Verreault et al. (61) includes three scales from the original IPO (62): Identity Diffusion, Primitive Defenses, and Impaired Reality Testing, along with a Global Personality Organization score. Items are scored on a five-point scale (range 1–5).

The five-item Satisfaction with Life Scale [SWLS; (63); French validation by Blais et al. (64)] uses straightforward probes about participants' life satisfaction. Items are scored on a seven-point scale (range 1–7).

The 10-item Rosenberg Self-Esteem Scale [RSES; (65); French validation by Vallières and Vallerand (66)] is a unidimensional measure of global self-esteem. Items are scored on a four-point scale (range 1–4).

Analytic Strategy

In a preliminary step, t-tests for independent samples were computed on the global SIFS score for men and women for each sample (with the exception of Sample 4 which only includes women), to rule out the need for separate cutoffs based on gender. The ensuing statistical analyses followed a four-step procedure. (a) The first step aimed at delineating participants with vs. without a personality disorder. This should establish a first threshold between the “No PD” and the “Personality Difficulty” groups, on the one hand, and the Mild-Moderate-Severe PD groups, on the other hand. In order to do so, we ran a Receiver Operating Characteristic (ROC) curve analysis, combining Samples 1 and 2 (PD patients) to form a first dichotomous groups (with PD), and combining Samples 4 and 5 (pregnant women and participants from the community) to form a second dichotomous group (without PD). Sample 3, recruited in private practice clinics, was excluded at this step, as the expected prevalence of PD in these clinical settings is uncertain. The ROC analysis allowed choosing a cutoff point to establish the presence of a PD; this cutoff was selected based on empirical considerations (i.e., optimal sensitivity-specificity based on Youden's index, Diagnostic odds ratio). It was also based on “clinical plausibility,” as the retained cutoff should yield a PD prevalence in non-clinical groups in the range observed in past epidemiological studies conducted in community samples. While the range of these estimates is quite large, from 4.4 (68) to 33.1% (69), the selected cutoff should ideally yield prevalence indices close to the median estimate of 11.5%, based on 14 major studies, reported by Morgan and Zimmerman (67).

(b) In a second step, delineation among the three categories where PD is present (Mild, Moderate, Severe) according to the ICD-11 model was established. This was computed using Latent Class Analysis (LCA) on the subsample of participants from all five samples identified as having a PD based on the threshold established in step (a). The SIFS total score was used as the sole latent indicator, and a predetermined number of three profiles was specified for the analysis. These profiles are thus expected to be established based on a gradient of severity; the Mild severity profile is expected to have more participants, while the Severe profile should have less, and the Moderate severity should be in between these two. Hallquist and Pilkonis (70), drawing on a previous work from Markon and Krueger (71), have commented on the potential use of LCA to determine severity degrees, suggesting that “when LCA supports the existence of two or more latent classes that differ by severity, the mean severity level for each class provides potential information about cut-points along a continuous severity dimension” (p. 229). Thus, means and standard deviations from the three profiles yielded by LCA were used to establish anchor points for the Mild, Moderate, and Severe categories.

(c) The third step involved delineating the “No PD” from the “Personality Difficulty” group. This latter group is defined in the ICD-11 PD model by the presence of long-standing difficulties in a person's way of experiencing and thinking about oneself, others, and the world; in contrast to PD proper, however, individuals with Personality Difficulty only show intermittent, or low intensity, manifestations of these difficulties in the cognitive, emotional, or behavioral domains (14). Thus, individuals with Personality Difficulty might be expected to be found in prospective patients referred to PD clinical programs in Samples 1 and 2, but who did not reach the diagnostic threshold for a PD. The delineation between No PD and Personality Difficulty was based on mean and standard deviation (i.e., within ≤ 1.0 SD) for these individuals.

(d) Finally, once anchor points were established for all five PD and non-PD categories, the last step involved their validation based on a set of external variables relevant for PD and general psychosocial functioning. The five samples included different sets of mostly non-overlapping self-report measures, tailored to their clinical context (e.g., more measures of externalizing pathology and potential for harm in the most severe samples). These measures should provide a wide range of clinical and functioning variables for validation. Samples were tested separately, using Kruskall-Wallis analysis (two-tailed, with Bonferroni's correction for multiple comparisons) to contrast categories, as the number of participants per category was likely to show marked differences. In Samples 1 and 2, the “No PD” category was omitted from analyses as it was expected to have a very low prevalence in these groups. The same goes for the “Severe PD” group in Samples 3, 4, and 5. Valid PD severity categories would be expected to show a gradient of severity (i.e., minimal pathology in the No PD group, and maximal pathology in the Severe group, with increments between intermediate categories). Contrasts between contiguous/consecutive categories (e.g., between No PD and Personality Difficulty, or between Moderate and Severe PD) were considered a stringent test of the discriminative power of the cutoffs established through steps (a) to (c).

Results

In a preliminary step, gender differences for the SIFS total score were ruled out for each sample: Sample 1 = Mwomen = 1.89, SD = 0.62; Mmen = 1.92, SD = 0.58; t(285) = −0.48, p = 0.63; Sample 2 = Mwomen = 1.66, SD = 0.61; Mmen = 1.75, SD = 0.56; t(246) = −1.18, p = 0.24; Sample 3 = Mwomen = 1.09, SD = 0.52; Mmen = 1.19, SD = 0.60; t(240) = −1.29, p = 0.20; Sample 5 = Mwomen = 0.97, SD = 0.48; Mmen = 1.01, SD = 0.50; t(261) = −0.57, p = 0.57. These results allowed determining common cutoffs for men and women in the ensuing analytic steps.

Delineation Between Participants With vs. Without PD

ROC analysis was performed using the SIFS total score as predictor of belonging to a PD group (Samples 1 and 2) vs. a non-clinical group (Samples 4 and 5; see Figure 1). Area under the curve was 0.90 (CI [0.88–0.92], SE = 0.01), an excellent accuracy with a large effect size (d = 1.84) according to established guidelines (72). Based on aforementioned criteria for cutoff selection, we chose 1.31 (rounded to 1.30; Sensitivity = 0.79, Specificity = 0.86, Diagnostic odds ratio = 23.23) as the cutoff between PD and absence of PD. This anchor point yielded the following prevalence for PD in our five samples: Sample 1 = 82.2%; Sample 2 = 71.3%; Sample 3 = 32.6%; Sample 4 = 11.2%; Sample 5 = 22.4%.

Figure 1

Receiver Operating Characteristic (ROC) curve using Self and Interpersonal Functioning Scale total score to discriminate between personality disorder and community samples. Personality disorder samples = combination of samples 1 and 2 (n = 536); Community samples = combination of samples 4 and 5 (n = 1,463). Area under curve = 0.90 (Confidence internal [0.88–0.92], Standard error = 0.01).

Delineation Among the Mild, Moderate, and Severe PD Groups Based on Degree of Severity

LCA was run using Mplus version 8.4 (73) on participants (n = 713) with a PD according to the 1.30 cutoff established in step (a), with the standardized SIFS total score as the profiling variable, forcing the analysis to extract three classes from data. The entropy figure (0.81) suggested an adequate classification according to usual guidelines (a score between 0.8 and 1.0 is generally considered adequate). The three classes, Mild, Moderate, and Severe PD, included, respectively, 439 (61.6%; M = 1.59, SD = 0.17), 213 (29.9%; M = 2.18, SD = 0.18), and 61 (8.6%; M = 2.84, SD = 0.23) participants.

Using SIFS means and standard deviations of roughly +/– 1.5 units for the three classes generated by LCA, the following anchor points were established for the three degrees of PD severity: Mild = 1.30–1.89; Moderate = 1.90–2.49; Severe = 2.50 and above (see Table 2).

Table 2

Distribution of participants from the five samples according to ICD-11 degrees of severity thresholds established with the Self and Interpersonal Functioning Scale total score.

		Clinical samples			Non-clinical samples
Category	SIFS score range	Sample 1	Sample 2	Sample 3	Sample 4	Sample 5
		(n = 287)	(n = 249)	(n = 242)	(n = 1,200)	(n = 263)
No PD	0–1.04	24 (8.4%)	32 (12.9%)	124 (51.2%)	927 (77.3%)	150 (57.0%)
Personality difficulty	1.05–1.29	21 (7.3%)	35 (14.1%)	33 (13.6%)	128 (10.7%)	53 (20.2%)
Mild PD	1.30–1.89	100 (34.8%)	95 (38.2%)	64 (26.4%)	126 (10.5%)	45 (17.1%)
Moderate PD	1.90–2.49	98 (34.1%)	62 (24.9%)	15 (6.2%)	18 (1.5%)	13 (4.9%)
Severe PD	2.50 and above	44 (15.3%)	25 (10.0%)	6 (2.5%)	1 (0.1%)	2 (0.8%)

ICD-11, 11th revision of the International Classification of Diseases; SIFS, Self and Interpersonal Functioning Scale; PD, Personality disorder; Sample 1, Specialized psychiatric outpatient clinic for more severe PD; Sample 2, Outpatient treatment establishments for less severe PD; Sample 3, Private practice clinics; Sample 4, Pregnant women; Sample 5, Community participants.

Delineating Absence of PD From Personality Difficulty

Using the subsample of patients from Samples 1 and 2 who did not reach the threshold for PD (n = 123), we computed their mean SIFS score (M = 1.29, SD = 0.26) to determine the cutoff for Absence of PD vs. Personality Difficulty. Using an estimate of 1.0 SD, the final threshold between these two categories was established at 1.03 (rounded to 1.05); therefore, the Personality Difficulty anchor points correspond to 1.05–1.29 (see Table 2).

In sum, the final thresholds, corresponding to ICD-11 PD degree of severity categories and based on SIFS total score, are as follows: Absence of PD = 0 to 1.04; Personality Difficulty = 1.05 to 1.29; Mild PD = 1.30 to 1.89; Moderate PD = 1.90 to 2.49; and Severe PD = 2.50 and above. Table 2 shows how participants from the five samples included in the present study are distributed along the five categories.

Validation of Categories With External Variables

Tables 3–7 display, for each sample, how participants from the five ICD-11 degree of severity categories differ across a number of external validation indices. Intergroup differences for the SIFS total score and elements are also presented but will not be considered as “external” comparators in the following analyzes as the ICD-11 categories are not statistically independent from these indices. A general pattern of results emerged in all five samples, as a clear gradient of severity across the five ICD-11 categories was observed. A high number of significant contrasts among PD categories were also observed.

Table 3

Comparisons among the ICD-11 personality disorders degrees of severity on external variables for sample 1 (specialized clinic for more severe personality disorders).

Scale	Statistic	Personality difficulty	Mild PD	Moderate PD	Severe PD	H
		(n = 21)	(n = 100)	(n = 98)	(n = 44)
SIFS total	M(SD)	1.27 (0.13)	1.70 (0.20)	2.19 (0.20)	2.78 (0.23)	217.46**
	MRb	14.12a	74.60b	167.32c	240.05d
SIFS identity	M(SD)	1.95 (0.49)	2.40 (0.56)	2.83 (0.50)	3.19 (0.46)	83.53**
	MRb	49.86a	100.33b	152.17c	198.26d
SIFS self-direction	M(SD)	1.13 (0.44)	1.74 (0.63)	2.24 (0.60)	3.01 (0.66)	108.58**
	MRb	40.57a	97.84b	149.16c	215.06d
SIFS empathy	M(SD)	0.74 (0.41)	1.02 (0.49)	1.61 (0.61)	2.36 (0.59)	120.57**
	MRb	57.02a	87.86a	154.02b	219.06c
SIFS intimacy	M(SD)	0.90 (0.37)	1.39 (0.56)	2.10 (0.65)	2.80 (0.67)	127.77**
	MRb	40.10a	88.24b	159.86c	213.41d
PID-5 negative affectivity	M(SD)	1.51 (0.48)	1.82 (0.59)	2.11 (0.51)	2.07 (0.55)	28.64**
	MRb	71.57a	115.36ac	153.71b	150.32bc
PID-5 detachment	M(SD)	1.12 (0.63)	1.35 (0.60)	1.57 (0.50)	1.92 (0.56)	37.04**
	MRb	84.31a	111.36a	140.12b	183.58c
PID-5 antagonism	M(SD)	0.38 (0.34)	0.47 (0.46)	0.77 (0.59)	1.23 (0.74)	44.10**
	MRb	93.48a	104.36a	143.77b	187.00c
PID-5 disinhibition	M(SD)	0.98 (0.42)	1.36 (0.52)	1.65 (0.53)	2.05 (0.47)	65.67**
	MRb	56.60a	107.00b	144.88c	196.13d
PID-5 psychoticism	M(SD)	0.46 (0.33)	0.79 (0.62)	0.98 (0.55)	1.22 (0.58)	35.56**
	MRb	70.81a	113.43a	145.67b	172.97b
BSL-23	M(SD)	1.42 (0.59)	1.83 (0.90)	2.28 (0.83)	2.56 (0.79)	36.76**
	MRb	70.76a	111.29a	147.13b	171.15b
PNI grandiose	M(SD)	1.71 (0.80)	2.01 (0.87)	2.52 (0.91)	2.77 (1.26)	30.59**
	MRb	85.21a	109.06a	148.76b	165.77b
PNI vulnerable	M(SD)	1.66 (0.80)	2.05 (0.80)	2.69 (0.81)	3.24 (0.88)	69.24**
	MRb	66.19a	99.27a	150.05b	193.88c
BPAQ total (trait aggression)	M(SD)	2.71 (0.92)	2.88 (0.90)	3.51 (1.02)	4.35 (0.96)	63.35**
	MRb	87.69a	98.53a	143.89b	199.01c
BPAQ verbal aggression	M(SD)	2.48 (0.79)	2.54 (1.06)	3.14 (1.18)	3.75 (1.27)	32.85**
	MRb	102.52ab	105.62b	143.67ac	176.45c
BPAQ physical aggression	M(SD)	2.29 (1.61)	2.17 (1.31)	2.68 (1.68)	3.69 (1.74)	25.33**
	MRb	110.69a	112.87a	133.53a	178.82b
BPAQ hostility	M(SD)	2.95 (1.31)	3.53 (1.21)	4.17 (1.22)	5.01 (1.06)	54.94**
	MRb	74.31a	105.35a	142.76b	192.68c
BPAQ anger	M(SD)	3.13 (1.34)	3.30 (1.39)	4.06 (1.25)	4.96 (1.16)	51.65**
	MRb	93.93ab	101.98a	141.52b	193.53c
IRI perspective takinga	M(SD)	4.94 (0.88)	4.86 (1.12)	4.27 (1.06)	3.12 (1.25)	60.25**
	MRb	169.07ab	162.75a	124.36b	61.45c
IRI empathic concerna	M(SD)	5.41 (0.88)	5.42 (0.97)	5.31 (1.29)	4.57 (1.28)	14.45*
	MRb	140.45ab	140.07b	139.86b	92.26ac
BIS-11 attentional	M(SD)	2.20 (0.42)	2.40 (0.51)	2.66 (0.43)	3.00 (0.40)	57.24**
	MRb	75.40a	104.33a	142.62b	194.64c
BIS-11 motor	M(SD)	1.85 (0.32)	2.17 (0.44)	2.41 (0.50)	2.89 (0.45)	72.27**
	MRb	57.50a	106.17b	140.71c	203.31d
BIS-11 non-planning	M(SD)	2.29 (0.31)	2.47 (0.35)	2.63 (0.41)	2.92 (0.41)	47.21**
	MRb	75.90a	108.31a	141.36b	188.38c

ICD-11, 11th revision of the International Classification of Diseases; MR, Mean rank; SIFS, Self and Interpersonal Functioning Scale; PID-5, Personality Inventory for DSM−5 Faceted Brief Form (100 items); BSL-23, 23-item Borderline Symptoms List; PNI, Brief Version of the Pathological Narcissism Inventory; BPAQ, 12-item version of the Buss-Perry Aggression Questionnaire; IRI, Interpersonal Reactivity Index; BIS-11, Barratt Impulsiveness Scale (version 11).

Higher scores denote better functioning. For all other variables, higher scores denote more severe pathology.

Mean rank with different subscripts (.

p < 0.01;

p < 0.001.

Table 7

Comparisons among the ICD-11 personality disorders degrees of severity on external variables for sample 5 (community participants).

Scale	Statistic	No PD	Personality difficulty	Mild PD	Moderate PD	H
		(n = 150)	(n = 53)	(n = 45)	(n = 13)
SIFS total	M(SD)	0.64 (0.22)	1.15 (0.08)	1.52 (0.14)	2.11 (0.16)	207.28**
	MRb	75.50a	177.50b	225.00c	255.00c
SIFS identity	M(SD)	0.90 (0.41)	1.47 (0.53)	1.85 (0.61)	2.69 (0.44)	118.23**
	MRb	90.04a	95.46b	162.74bc	246.46c
SIFS self-direction	M(SD)	0.83 (0.44)	1.28 (0.40)	1.60 (0.56)	1.94 (0.62)	91.94**
	MRb	94.38a	161.36b	191.82b	219.23b
SIFS empathy	M(SD)	0.43 (0.31)	0.83 (0.41)	1.18 (0.48)	1.48 (0.52)	115.34**
	MRb	90.71a	159.19b	205.44c	230.15c
SIFS intimacy	M(SD)	0.45 (0.39)	1.01 (0.48)	1.43 (0.56)	2.21 (0.45)	129.33**
	MRb	88.02a	164.92a	204.11b	245.92b
PID-5 negative affectivity	M(SD)	0.88 (0.47)	1.24 (0.59)	1.49 (0.61)	1.72 (0.52)	71.71**
	MRb	87.25a	136.72b	165.72bc	194.86c
PID-5 detachment	M(SD)	0.36 (0.34)	0.68 (0.43)	1.02 (0.47)	1.59 (0.18)	95.51**
	MRb	82.51a	126.81b	165.85b	217.86c
PID-5 antagonism	M(SD)	0.46 (0.47)	0.53 (0.39)	0.57 (0.49)	0.70 (0.50)	12.77**
	MRb	104.76a	126.80ab	140.26b	144.79ab
PID-5 disinhibition	M(SD)	0.63 (0.43)	0.90 (0.52)	1.09 (0.53)	1.20 (0.48)	13.33**
	MRb	104.24a	128.66ab	139.95b	144.46ab
PID-5 psychoticism	M(SD)	0.20 (0.29)	0.31 (0.33)	0.46 (0.51)	0.92 (0.60)	35.76**
	MRb	98.73a	129.07ab	139.13b	196.68c
IRI perspective takinga	M(SD)	5.30 (0.76)	4.99 (0.87)	4.95 (0.86)	4.34 (1.12)	15.91*
	MRb	138.60a	115.36ab	109.30ab	71.89b
IRI empathic concerna	M(SD)c	5.56 (1.12)	5.35 (0.94)	5.54 (0.92)	5.27 (1.07)	3.71
IPO total	M(SD)	1.54 (0.27)	1.77 (0.33)	2.02 (0.45)	2.32 (0.55)	74.05**
	MRb	93.46a	142.91b	185.12bc	201.96c
IPO identity	M(SD)	2.07 (0.48)	2.45 (0.54)	2.74 (0.55)	2.89 (0.81)	59.37**
	MRb	96.54a	143.55b	175.92b	185.32b
IPO defense mechanisms	M(SD)	1.46 (0.40)	1.85 (0.58)	2.10 (0.63)	2.59 (0.89)	66.50**
	MRb	95.69a	145.19b	173.32b	201.64b
IPO reality testing	M(SD)	1.19 (0.30)	1.22 (0.21)	1.43 (0.58)	1.71 (0.50)	28.59**
	MRb	110.59a	131.88ab	147.50b	204.64c
SWLSa	M(SD)	5.76 (0.90)	5.11 (0.94)	4.25 (1.11)	3.31 (1.42)	86.14**
	MRb	161.38a	113.34b	67.90c	42.00c
RSESa	M(SD)	3.49 (0.39)	3.09 (0.40)	2.57 (0.54)	2.33 (0.47)	100.44**
	MRb	167.50a	105.71ab	70.58b	30.57c

ICD-11, 11th revision of the International Classification of Diseases; SIFS, Self and Interpersonal Functioning Scale; MR, Mean rank; PID-5, Personality Inventory for DSM−5 Faceted Brief Form (100 items); IPO, Brief 19-item version of the Inventory of Personality Organization; SWLS, Satisfaction with Life Scale; RSES, Rosenberg Self-Esteem Scale.

Higher scores denote better functioning. For all other variables, higher scores denote more severe pathology.

Mean rank with different subscripts (.

Mean rank not shown in the absence of significant contrasts.

p < 0.01;

p < 0.001.

In the most severe sample (Sample 1), there was a remarkably neat break between the Mild and Moderate categories, as significant differences were observed for 16 out of 18 comparisons. There was also a clear delineation between the Moderate and Severe categories, with 13 out of 18 contrasts yielding significant results. Fewer differences (two) were observed between the Personality Difficulty vs. Mild categories. Of note, two comparators (PID-5 Disinhibition and BIS-11 Motor impulsivity) showed a high discriminant capacity, with significant differences across all four ICD-11 categories tested in that sample (see Table 3). The other PD sample (Sample 2) showed a similar pattern of results, with a clear gradient of severity across PD severity categories for all external variables, although less significant contrasts between contiguous categories were observed: four out of eight for Personality Difficulty vs. Mild PD (PID-5 Disinhibition and Psychoticism, PNI Grandiosity and Vulnerability), three out of eight for Mild vs. Moderate PD (PID-5 Negative Affectivity and Detachment, PNI Vulnerability), and one out of eight for Moderate vs. Severe PD (BSL-23 Borderline symptoms; see Table 4).

Table 4

Comparisons among the ICD-11 personality disorders degrees of severity on external variables for sample 2 (specialized clinic for less severe personality disorders).

Scale	Statistic	Personality difficulty	Mild PD	Moderate PD	Severe PD	H
		(n = 35)	(n = 95)	(n = 62)	(n = 25)
SIFS total	M(SD)	1.17 (0.08)	1.61 (0.16)	2.15 (0.15)	2.80 (0.22)	191.76**
	MRa	18.00a	83.00b	161.59c	205.00d
SIFS identity	M(SD)	1.82 (0.49)	2.40 (0.53)	2.84 (0.49)	3.23 (0.43)	89.47**
	MRa	42.90a	94.62b	141.02c	176.76c
SIFS self-direction	M(SD)	1.34 (0.52)	1.78 (0.62)	2.24 (0.64)	2.94 (0.64)	75.00**
	MRa	55.83a	93.87b	132.06c	183.88d
SIFS empathy	M(SD)	0.67 (0.34)	1.13 (0.49)	1.58 (0.56)	2.45 (0.63)	98.47**
	MRa	42.97a	93.81b	137.03c	189.66d
SIFS intimacy	M(SD)	0.82 (0.43)	1.10 (0.58)	1.89 (0.50)	2.54 (0.64)	109.17**
	MRa	55.17a	81.52a	150.26b	186.60b
PID-5 negative affectivity	M(SD)	1.51 (0.59)	1.70 (0.56)	1.95 (0.53)	2.22 (0.46)	30.05**
	MRa	79.01a	96.68a	126.29b	154.90b
PID-5 detachment	M(SD)	0.80 (0.50)	1.05 (0.61)	1.43 (0.51)	1.86 (0.53)	53.22**
	MRa	67.60a	93.12a	132.58b	168.84b
PID-5 antagonism	M(SD)	0.49 (0.45)	0.67 (0.60)	0.90 (0.58)	1.17 (0.54)	26.16**
	MRa	80.51ab	97.20ab	124.02bc	151.68c
PID-5 disinhibition	M(SD)	0.83 (0.41)	1.16 (0.48)	1.36 (0.57)	1.67 (0.65)	34.57**
	MRa	63.34a	104.01b	126.05bc	149.62c
PID-5 psychoticism	M(SD)	0.73 (0.44)	1.13 (0.57)	1.22 (0.55)	1.61 (0.73)	27.60**
	MRa	66.09a	108.15b	119.07bc	147.54c
BSL-23	M(SD)	1.39 (0.78)	1.80 (0.84)	1.94 (0.89)	2.69 (0.76)	32.32**
	MRa	73.84a	102.84ab	115.82b	164.72c
PNI grandiose	M(SD)	1.71 (0.86)	2.28 (0.80)	2.44 (0.76)	2.42 (0.81)	16.75*
	MRa	70.50a	111.98b	120.28b	123.60b
PNI vulnerable	M(SD)	1.63 (0.79)	2.24 (0.67)	2.78 (0.72)	3.11 (0.84)	59.15**
	MRa	55.16a	96.48b	138.25c	159.42c

ICD-11, 11th revision of the International Classification of Diseases; MR, Mean rank; SIFS, Self and Interpersonal Functioning Scale; BSL-23, 23-item Borderline Symptoms List; PNI, Brief Version of the Pathological Narcissism Inventory; PID-5, Personality Inventory for DSM−5 Brief Form (25 items).

Mean rank with different subscripts (.

p < 0.01;

p < 0.001.

Comparisons for Samples 3 to 5 did not include the Severe PD category. Again, the expected pattern of increased severity was observed across degrees of severity. In the private practice sample (Sample 3), the following significant contrasts were observed for contiguous categories: two out of eight for No PD vs. Personal difficulty (PID-5 Detachment; PSI symptoms); none between Personality Difficulty and Mild PD, and also none between Mild and Moderate PD. Of note, ECR-12 attachment avoidance did not show any significant difference across degrees of severity (see Table 5). In Sample 4 (pregnant women from the community), significant contrasts for contiguous categories were as follows: six out of seven for No PD vs. Personality Difficulty (K-10 psychological symptoms; EPDS depression; PANAS Negative Affect; DES Absorption and Derealization; PCL-5 trauma); five out of seven between Personality Difficulty and Mild PD (K-10 psychological symptoms; EPDS depression; DES Absorption and Depersonalization; PCL-5 trauma); and none between Mild and Moderate PD (see Table 6). Finally, for Sample 5, significant contrasts for contiguous categories were as follows: six out of 13 for No PD vs. Personality Difficulty (PID-5 Negative Affectivity; IPO Global Personality Organization, Identity Diffusion, and Primitive Defenses; SWLS Satisfaction with life; and RSES Self-esteem); one out of 13 between Personality Difficulties and Mild PD (SWLS Satisfaction with life); and three out of 13 between Mild and Moderate PD (PID-5 Psychoticism; IPO Reality Testing; RSES Self-esteem). IRI Empathic Concern had no discriminant power to distinguish PD degrees of severity (see Table 7).

Table 5

Comparisons among the ICD-11 personality disorders degrees of severity on external variables for sample 3 (private practice clinics).

Scale	Statistic	No PD	Personality difficulty	Mild PD	Moderate PD	H
		(n = 124)	(n = 33)	(n = 64)	(n = 15)
SIFS total	M(SD)	0.70 (0.20)	1.17 (0.08)	1.56 (0.17)	2.13 (0.13)	195.70*
	MRa	62.50a	141.00b	185.50c	229.00c
SIFS identity	M(SD)	1.11 (0.51)	1.79 (0.54)	2.17 (0.66)	2.80 (0.48)	116.57*
	MRa	75.31a	140.58b	168.77bc	212.47c
SIFS self-direction	M(SD)	0.83 (0.45)	1.41 (0.39)	1.71 (0.72)	2.25 (0.77)	93.30*
	MRa	79.20a	145.91b	161.99b	197.59b
SIFS empathy	M(SD)	0.43 (0.30)	0.78 (0.46)	1.08 (0.54)	1.70 (0.52)	98.95*
	MRa	79.83a	132.44b	164.70bc	210.37c
SIFS intimacy	M(SD)	0.40 (0.29)	0.72 (0.33)	1.25 (0.58)	1.74 (0.70)	113.11*
	MRa	77.04a	127.33b	174.68c	202.07c
PID-5 negative affectivity	M(SD)	0.95 (0.49)	1.19 (0.57)	1.49 (0.56)	1.71 (0.57)	47.07*
	MRa	90.96a	117.96ab	151.67bc	174.74c
PID-5 detachment	M(SD)	0.37 (0.31)	0.67 (0.48)	0.85 (0.42)	1.29 (0.53)	74.68*
	MRa	83.06a	126.81b	158.04bc	195.11c
PID-5 antagonism	M(SD)	0.42 (0.36)	0.34 (0.30)	0.58 (0.48)	0.76 (0.51)	13.21*
	MRa	110.48a	99.16a	131.25ab	157.74b
PID-5 disinhibition	M(SD)	0.68 (0.44)	0.89 (0.46)	1.14 (0.54)	1.43 (0.71)	39.67*
	MRa	92.65a	120.97ab	145.23b	169.63b
PID-5 psychoticism	M(SD)	0.24 (0.29)	0.34 (0.42)	0.47 (0.39)	0.71 (0.59)	26.23*
	MRa	98.42a	115.23ab	144.10b	158.79b
PSI total	M(SD)	0.86 (0.42)	1.15 (0.46)	1.36 (0.61)	1.64 (0.54)	50.76*
	MRa	88.72a	128.28b	147.95bc	180.53c
ECR anxiety	M(SD)	3.59 (1.23)	4.19 (1.30)	4.84 (1.21)	4.50 (1.72)	37.92*
	MRa	92.15a	120.50ab	155.74bc	136.53abc
ECR avoidance	M(SD)b	2.48 (1.08)	2.90 (1.22)	2.81 (1.11)	2.76 (0.96)	4.92

ICD-11, 11th revision of the International Classification of Diseases; PD, Personality disorder; MR, Mean rank; SIFS, Self and Interpersonal Functioning Scale; PID-5, Personality Inventory for DSM-5 Faceted Brief Form (100 items); PSI, 14-item version of the Psychiatric Symptom Index; ECR, shortened 12-item version of the Experiences in Close Relationships questionnaire.

Mean rank with different subscripts (.

Mean rank not shown in the absence of significant contrasts.

p < 0.001.

Table 6

Comparisons among the ICD-11 personality disorders degrees of severity on external variables for sample 4 (pregnant women).

Scale	Statistic	No PD	Personality difficulty	Mild PD	Moderate PD	H
		(n = 927)	(n = 128)	(n = 126)	(n = 18)
SIFS total	M(SD)	0.61 (0.23)	1.14 (0.08)	1.54 (0.16)	2.11 (0.16)	642.23*
	MRb	464.00a	991.50b	1118.50bc	1190.50c
SIFS identity	M(SD)	0.86 (0.38)	1.39 (0.38)	1.97 (0.47)	2.11 (0.51)	436.61*
	MRb	490.39a	865.25b	1056.89bc	1090.28c
SIFS self-direction	M(SD)	0.78 (0.43)	1.37 (0.49)	1.68 (0.51)	2.04 (0.60)	355.76*
	MRb	500.30a	862.90b	998.84bc	1073.19c
SIFS empathy	M(SD)	0.46 (0.33)	0.93 (0.39)	1.28 (0.49)	2.15 (0.57)	392.89*
	MRb	496.08a	867.75b	1041.38c	1168.14c
SIFS intimacy	M(SD)	0.37 (0.31)	0.89 (0.43)	1.25 (0.53)	2.13 (0.45)	394.87*
	MRb	495.48a	876.46b	1095.87c	1175.67c
K-10	M(SD)	2.00 (0.64)	2.33 (0.60)	2.70 (0.63)	2.83 (0.56)	157.00*
	MRb	519.43a	697.26b	872.00c	945.06c
EPDS	M(SD)	1.82 (0.46)	2.13 (0.49)	2.35 (0.52)	2.48 (0.41)	149.60*
	MRb	524.27a	722.01b	851.15c	942.08bc
PANAS positive affecta	M(SD)	2.81 (0.62)	2.70 (0.58)	2.61 (0.58)	2.48 (0.41)	18.03*
	MRb	595.40a	528.30ab	492.79b	380.47b
PANAS negative affect	M(SD)	2.17 (0.67)	2.62 (0.72)	2.77 (0.71)	2.87 (0.50)	118.63*
	MRb	523.55a	728.25b	802.84b	876.15b
DES absorption	M(SD)	1.37 (1.19)	2.38 (1.69)	3.07 (1.89)	3.45 (1.88)	155.98*
	MRb	525.13a	716.34b	862.23c	937.00bc
DES depersonalization	M(SD)	0.41 (0.92)	1.10 (1.82)	1.66 (2.18)	2.05 (2.45)	110.66*
	MRb	542.43a	623.52b	813.52c	857.81bc
PCL-5	M(SD)	0.56 (0.51)	0.95 (0.68)	1.27 (0.68)	1.34 (0.57)	174.68*
	MRb	500.72a	723.38b	860.57c	910.94bc

ICD-11, 11th revision of the International Classification of Diseases; SIFS, Self and Interpersonal Functioning Scale; MR, Mean rank; K-10, Kessler Psychological Distress Scale; EPDS, Edinburgh Perinatal/Postnatal Depression Scale; PANAS, Positive and Negative Affect Schedule; DES, Dissociative Experiences Scale; PCL-5, Posttraumatic Stress Disorder Checklist for DSM-5.

Higher scores denote better functioning. For all other variables, higher scores denote more severe pathology.

Mean rank with different subscripts (.

p < 0.001.

Discussion

The aim of the present study was to propose an empirically-based classification of the five ICD-11 PD degrees of severity based on the SIFS, a self-report questionnaire that was originally developed to operationalize the level of functioning criterion from the DSM-5 AMPD. Across five clinical and non-clinical samples, we found consistent support for a graduated classification of severity, based on the five categories from the ICD-11 PD model, which range from “No PD” to “Severe PD.” Results tend to support the validity of the proposed anchor points, which were based on the SIFS' total score. They also substantiate the suggestion that diagnostic information from instruments originally developed for Criterion A of the DSM-5 AMPD model can be used with confidence for the ICD-11 PD model's severity classification (13). More generally, our findings also constitute further evidence that general PD severity is a strong predictor of current symptomatology and distress [e.g., (19, 20)].

Prevalence of PD (i.e., as indicated by a score falling within the Mild, Moderate, or Severe PD categories) was very high in PD samples (84.3 and 73.0%), as expected. The prevalence in private practice was 35.1%, with very few participants in the Moderate or Severe categories. This is consistent with the fact that getting treatment in private practice, because of the costs incurred, most generally requires at least some capacity to maintain a source of revenue and thus to be able to sustain employment, which is a characteristic of Mild PD in contrast with the two most severe categories in the ICD-11 model (14). Prevalence in community participants was 12.1% in the sample of pregnant women, and 22.8% in the community sample collected for initial validation of the SIFS; in both cases, severe cases were extremely rare (<1%). The prevalence for the latter sample, while falling within the range (4.4–33.1%) of previous epidemiological studies on PD prevalence, is still noticeably higher than the median of 11.5% reported in a recent review of 14 large-scale studies (67). This result might be partially explained by a self-selection bias, as participants from Sample 5 were aware that they were contributing to a study aiming to validate a self-report pertaining to personality functioning; this may have inadvertently attracted participants with personality issues. Nonetheless, these figures are both in a plausible range, which supports the validity of the proposed cutoff between PD and absence of PD. In addition, results from the ROC curve analysis strengthen findings regarding the validity of the SIFS, which showed an excellent capacity to classify participants from PD groups vs. community samples.

External validation of the five categories from the ICD-11 PD model showed a clear gradient of severity, in all samples, and for virtually all the tested variables; a high number of meaningful differences, both from a statistical and a clinical standpoint, were found. The most striking differences were found in the most severe sample (Sample 1), as there was a very clear delineation among the Mild, Moderate, and Severe categories. These differences were very apparent on external variables reflective of externalizing pathology, notably aggression and impulsivity. This is especially important to support the validity of our classification, as the ICD-11 PD model stresses that the risk of harm to self and others is an important distinction among degrees of severity. It also supports the hypothesis from members of the ICD-11 PD Working Group, which was initially formulated about the borderline PD diagnosis specifically, “that individuals with mild personality disorder will display largely negative affective symptoms, whereas those with more severe disturbance will also have disinhibited and dissocial behaviors [emphasis added]” [(4), p. 495]. It also mitigates potential concerns regarding the SIFS' capacity for discrimination based on those variables, as the instrument was primarily developed to assess self and interpersonal dysfunction based on the AMPD model. In non-clinical samples, the most apparent distinctions were observed in Sample 4 (pregnant women), with the cleanest break being observed between the Personality Difficulty and Mild PD degrees; as measures in that sample mostly focused on internalizing pathology (e.g., depression, trauma, negative affectivity, dissociation), these results highlight the SIFS' capacity to discriminate among degrees of severity based on personal distress, which is key to discriminate between Personality Difficulty (where distress is expected to be transient or of low intensity) and Mild PD (where distress may be substantial) in the ICD-11 PD model.

However, it should be noted that the SIFS' capacity for fine-grained discrimination among severity degrees, as measured by the presence of statistically significant differences between contiguous categories, was uneven across samples. Interestingly, the scale's discriminant capacity was at its best in the most severe sample of PD patients (see Table 3), which supports Waugh et al.'s (25) conclusion that the SIFS seems more pathology-focused, and showed a lower discriminant capacity in the private practice sample (see Table 5). One possible—and intriguing—possibility is that “isomorphism” between structural personality deficits assessed by degree of severity measures and external correlates reflective of externalizing and/or internalizing symptoms may be at its highest in clinical samples where patients are the most dysfunctional. In contrast, in private practice patients, there might be a more pronounced gap, as “structural” deficits may be present but with less apparent impact, which is notably reflected in a preserved ability to maintain employment, a prerequisite in most cases to afford psychotherapy in private settings. Other factors, such as issues pertaining to statistical power (with notable differences between group sizes to test for contrasts), also likely played a role.

The main limitation of the present study is the sole reliance on self-reported variables as external validators. While evidence supporting the validity and usefulness of self-ratings of personality pathology is mounting [e.g., (74, 75)], the impact of response style bias as a potential confounding variable could not be taken into account. Future investigations of the validity of the present degrees of severity should not only include multiple instruments, but also multiple methods, as well as longitudinal and behavioral outcomes assessment, most notably to assess the risk of harm to self and others. The lack of uniformity among batteries of measures in the different samples is also a noteworthy limitation, and hampers some potentially useful comparisons. Precise estimation of participants' ethnic background was unavailable, but data were collected in overwhelmingly Caucasian-white communities, which limits generalization of the findings, given than ethnicity has a well-documented impact on PD epidemiology [e.g., (76)]; this calls for inclusion of more diverse samples in future research. There was a significantly unbalanced male-female ratio in the total sample as well as across the four mixed-gender samples (1, 2, 3, and 5).

In sum, the present study provides potentially useful guidelines to determine severity of personality pathology based on the ICD-11 model, using a short self-report questionnaire, the Self and Interpersonal Functioning Scale. Results suggest that the SIFS total score can be used with confidence as a screening tool for provisional assessment of PD severity; it showed a strong capacity, in five independent samples, to classify patients in categories that were meaningfully associated with a number of indices of externalizing and internalizing symptomatology relevant to PD. The present study should be seen as a positive step in the validation of time-efficient, accessible, and cost-effective clinical strategies to overcome the reluctance of some clinicians to diagnose PD, as it is often perceived as difficult, time-consuming, and off-putting [e.g., (29, 77)]. Indeed, the empirically-based anchors presented in this study are straightforward in their interpretation, which is likely to make them appealing for screening purposes to many clinicians irrespective of their PD assessment expertise. In addition, the SIFS provides an opportunity to assess personality pathology in a way that bridges the North American and European emerging conceptualizations of PD severity, with self and interpersonal deficits at their core. In order to rule on the validity of the proposed anchor points, future studies should focus on their usefulness to guide intensity of clinical treatment and to predict treatment course (13).

Data Availability Statement

The datasets presented in this article are not readily available because Ethics approval did not include sharing of the dataset for the present research. Upon reasonable request, the dataset could be shared, contingent upon the approval of an amendment by ethics committees that authorized the present research. Requests to access the datasets should be directed to dominick.gamache@uqtr.ca.

Ethics Statement

The studies involving human participants were reviewed and approved by Ethics committees from the Université du Québec at Trois-Rivières, the Université Laval, the Integrated University Health and Social Services Center of the Capitale-Nationale Sectoral Research Ethics Committee in Neurosciences and Mental Health, and the Integrated University Health and Social Services Center of the Mauricie-et-du-Centre-du-Québec. The patients/participants provided their written informed consent to participate in this study.

Author Contributions

DG and CS designed the study, drafted the first version of the manuscript, analyzed, and interpreted the data. CS drafted the grant proposals that secured financing for the study with the contribution of DG, NB, and MT. CS, NB, and RL drafted the ethics approval demands with the contribution of DG. CS, PL, MP, ML, KM, M-CN, and MT made substantial contributions to data acquisition. PL, NB, AC, JF, RL, KM, and M-CN made substantial revisions to the original draft. All authors have read the manuscript and have approved its submission in the present form.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.